Apyx medical corporation to release first quarter of fiscal year 2025 financial results on may 8, 2025

Clearwater, fla., april 24, 2025 (globe newswire) -- apyx medical corporation (nasdaq: apyx) (“apyx medical;” the “company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as renuvion®, today announced that financial results for the first quarter of fiscal year 2025 will be released before markets open on thursday, may 8th.
APYX Ratings Summary
APYX Quant Ranking